| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d986d3b448b2adf84ef6218aa81d0d07 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0088 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00 |
| filingDate |
2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5635da07fff2a3ac1b6926cf0897b13d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cdca309be45170c725c953c72d45f72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2baf4c7047e8ab6252275268f61475af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93738d4d3a68e2c8c1ed559481a2ae30 |
| publicationDate |
2022-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112018016341-B1 |
| titleOfInvention |
CATHETER BLOCKING SOLUTION |
| abstract |
Various modalities refer to catheter lock solutions and catheter lock therapies using trisodium citrate and ethyl alcohol, and in particular 4.0 to 15.0% w/v of trisodium citrate as an anticoagulant and/or antibacterial component and 15.0 to 25.0% volume/volume of ethyl alcohol as an antibacterial component. The use of catheter lock solution and catheter lock therapy can reduce treatment failure during medical procedures that may employ catheters to provide treatment at least significantly reducing the risks associated with bloodstream infections, catheter system malfunction , emboli formation, patient discomfort and patient illness. These benefits may be partially due to the synergistic antibacterial effects of trisodium citrate and ethyl alcohol in solution, generating an effective catheter lock solution with minimal concentrations of ethyl alcohol. |
| priorityDate |
2016-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |